Genfit Reports Strong Financial Performance in FY 2023

Friday, 5 April 2024, 12:28

French biotech company Genfit has reported a significant increase in revenue for the fiscal year 2023, reaching €38.2 million compared to €26.6 million in 2022. Despite this positive growth, Genfit also recorded an EPS loss of €0.58, highlighting potential challenges in profitability.
LivaRava Finance Meta Image
Genfit Reports Strong Financial Performance in FY 2023

Genfit FY Results

French biotech company Genfit reported €38.2 million in revenue for 2023, compared to €26.6 million in 2022, along with an EPS loss of €0.58.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe